Medtronic (MDT) Capital Expenditures (2014 - 2026)

For the trailing twelve months through Jul 31, 2026, Capital Expenditures at Medtronic was $1.9 billion, up 3.3% year-over-year; for FY2026 (ended Apr 24, 2026), it was $1.9 billion, up 2.4% from FY2025.

• Annual Capital Expenditures has increased for eight consecutive fiscal years, with a five-year compound annual growth rate of 7.0% (FY2021 to FY2026).
• In prior fiscal years, Medtronic's Capital Expenditures was $1.86 billion in FY2025 (+17.1%), $1.59 billion in FY2024 (+8.8%), $1.46 billion in FY2023 (+6.7%) and $1.37 billion in FY2022 (+1.0%).
• Quarterly Capital Expenditures has run from a low of $271 million in fiscal Q2 2022 to a high of $520 million in fiscal Q1 2025 over five years.
• On a year-over-year basis, Capital Expenditures increased in four of the last eight quarters, with growth averaging 5.6%.
• The strongest year-over-year quarter for Capital Expenditures in the past five years was fiscal Q1 2025, with growth of 46.9%; the weakest was fiscal Q1 2024, with a decline of 16.9%.
• According to Business Quant data, Capital Expenditures for the three prior fiscal quarters was $488 million (Q4 2026), $444 million (Q3 2026) and $468 million (Q2 2026).